Real-World Occurrence of Symptoms and Toxicities and Associated Cost Implications in Acute Myeloid Leukemia (AML) Treatment Episodes: A Retrospective Database Analysis in the US

被引：0
|
作者：
Pandya, Bhavik J.
Medeiros, Bruno C.
Chen, Chi-Chang
Wilson, Samuel
Groves, Eric S.
Horvath, Laura Elise
Wade, Rolin L.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2118
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Economic Burden of Treatment Episodes in Acute Myeloid Leukemia (AML) Patients in the US: A Retrospective Analysis of a Commercial Payer Database
    Medeiros, Bruno C.
    Pandya, Bhavik J.
    Chen, Chi-Chang
    Groves, Eric S.
    Bui, Cat N.
    Horvath, Laura Elise
    Wade, Rolin L.
    BLOOD, 2017, 130
  • [2] Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) Associated with PARP Inhibitors: A Real-World Analysis
    Gajra, Ajeet
    Zettler, Marjorie E.
    Klink, Andrew J.
    Feinberg, Bruce
    BLOOD, 2020, 136
  • [3] Real-world (RW) use of venetoclax (VEN) in patients (pts) with acute myeloid leukemia (AML) in a US RWE database (COTA)
    Zeidan, Amer Methqal
    Donoso, Leyla Hernandez
    Hodzic, Sejla
    Owusu, Henry F.
    Pathak, Dhrubajyoti
    Zhou, Summera Qiheng
    Stein, Eytan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Real-World (RW) Outcomes With Venetoclax (VEN) in Patients With Acute Myeloid Leukemia (AML) From COTA, a US RW Evidence Database
    Stein, Eytan
    Hodzic, Sejla
    Owusu, Henry
    Pathak, Dhrubajyoti
    Zhou, Summera
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S288 - S289
  • [5] Real-World Utilization of Midostaurin Among Patients with Acute Myeloid Leukemia (AML)
    Gajra, Ajeet
    Klink, Andrew J.
    Kish, Jonathan K.
    Chopra, Dhruv
    Feinberg, Bruce
    BLOOD, 2019, 134
  • [6] Real-World Study of CPX-351 Treatment Outcomes for Acute Myeloid Leukemia (AML) in England
    Legg, Alex
    Doubleday, Pesheya
    Reich, Adam
    Lambova, Alexandrina
    Medalla, Greg
    BLOOD, 2021, 138
  • [7] Real-World Treatment Patterns Among Patients with Newly-Diagnosed (ND)-Acute Myeloid Leukemia (AML) in the United States (US)
    Pulte, Dianne
    Norsworthy, Kelly J.
    Fernandes, Laura
    Kanapuru, Bindu
    Lerro, Catherine
    Rizvi, Fatima
    Vallejo, Jonathon
    Wang, Kun
    Wynne, Joseph
    Barcellos, Anna
    Belli, Andrew J.
    Hansen, Eric
    Gwise, Thomas
    Kluetz, Paul
    De Claro, Angelo
    Wang, Ching-Kun
    Rivera, Donna
    BLOOD, 2022, 140 : 5100 - 5102
  • [8] Real-world practice patterns and barriers to quality care in acute myeloid leukemia (AML).
    Hussein, Maen A.
    Patel, Taral
    Ellipeddi, Pavani
    Farris, Breanne
    Crawford, Rebecca R.
    Carter, Jeffrey D.
    Sapir, Tamar
    Wang, Eunice S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Real-world examination of remission patterns in patients (pts) with acute myeloid leukemia (AML).
    Tabah, Ashley
    Huggar, David
    Brady, Brenna L.
    Jariwala-Parikh, Krutika
    Copher, Ronda
    LeBlanc, Thomas William
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Economic and Clinical Burden of Relapsed and/or Refractory Active Treatment Episodes in Patients with Acute Myeloid Leukemia (AML) in the USA: A Retrospective Analysis of a Commercial Payer Database
    Bhavik J. Pandya
    Chi-Chang Chen
    Bruno C. Medeiros
    Catherine B. McGuiness
    Samuel Wilson
    L. Elise Horvath Walsh
    Rolin L. Wade
    Advances in Therapy, 2019, 36 : 1922 - 1935
12345